mhurhangee/ep-ind-claims huggingface dataset:
A method for generating data of a Media Access Control, MAC, layer in a wireless communication system, the method comprising: generating an MAC Protocol Data Unit, MPDU, data portion by reconstructing an MAC Service Data Unit, MSDU, for a connection; generating (407, 409) an MPDU by adding a first header and a second header to the MPDU data portion; and transmitting the MPDU to a receive end, wherein the first header comprises a length of the MPDU and a connection identifier, and wherein the second header comprises a field representing the type of the second header and fragmentation information indicating whether a start byte of the MPDU data portion is same to a start byte of the at least one MSDU and whether a last byte of the MPDU data portion is same to a last byte of the at least one MSDU. generating an MAC Protocol Data Unit, MPDU, data portion by reconstructing an MAC Service Data Unit, MSDU, for a connection; generating (407, 409) an MPDU by adding a first header and a second header to the MPDU data portion; and transmitting the MPDU to a receive end, wherein the first header comprises a length of the MPDU and a connection identifier, and wherein the second header comprises a field representing the type of the second header and fragmentation information indicating whether a start byte of the MPDU data portion is same to a start byte of the at least one MSDU and whether a last byte of the MPDU data portion is same to a last byte of the at least one MSDU.
A system for generating a dynamic content presentation, comprising: a dynamic story creation module coupled to a selection module, where the selection module is to track and record steps taken by an author in a process for selecting a dynamic element of the dynamic content presentation, and wherein metadata tags are to be generated for each dynamic element with information corresponding to the tracked steps; a dynamic contextual replacement module to selectively replace the dynamic element according to selection criteria and context criteria stored in the metadata tag corresponding to a dynamic meta-object, the meta-object to enable dynamic presentation by collecting parameters expressed by the at least one metadata tag for use in identifying and replacing the dynamic element with a new element relevant to context of a viewer of the presentation, wherein the replacement module to replace the dynamic element corresponding to the dynamic meta-object in response to finding a broken link retrieving the dynamic element during playback; and a metadata correlation module to correlate the selection criteria used in the process for selecting the dynamic element with the metadata tags corresponding to the dynamic element and with the context criteria for replacing the dynamic element based on contextual information corresponding to the viewer, and further to generate a metadata tag package for the presentation, wherein the metadata tag package, comprising a metadata correlation of meta-objects and metadata tags, is a shorthand representation of the meta-object used for curating the broken link. a dynamic story creation module coupled to a selection module, where the selection module is to track and record steps taken by an author in a process for selecting a dynamic element of the dynamic content presentation, and wherein metadata tags are to be generated for each dynamic element with information corresponding to the tracked steps; a dynamic contextual replacement module to selectively replace the dynamic element according to selection criteria and context criteria stored in the metadata tag corresponding to a dynamic meta-object, the meta-object to enable dynamic presentation by collecting parameters expressed by the at least one metadata tag for use in identifying and replacing the dynamic element with a new element relevant to context of a viewer of the presentation, wherein the replacement module to replace the dynamic element corresponding to the dynamic meta-object in response to finding a broken link retrieving the dynamic element during playback; and a metadata correlation module to correlate the selection criteria used in the process for selecting the dynamic element with the metadata tags corresponding to the dynamic element and with the context criteria for replacing the dynamic element based on contextual information corresponding to the viewer, and further to generate a metadata tag package for the presentation, wherein the metadata tag package, comprising a metadata correlation of meta-objects and metadata tags, is a shorthand representation of the meta-object used for curating the broken link.
A spinal fusion implant (101, 102, 103, 104) for keeping relative positions of neighboring vertebral bodies to fall within a predetermined range, comprising: screws configured to be connected to vertebral bodies; at least two connection plates in each of which guide holes into which the screws are inserted from a back side surface toward a belly side surface are formed at both end portions; and a center rod which connects neighboring ones of the connection plates which are configured to be fixed to the vertebral bodies by the screws, each of the connection plates having, on the belly side surface, protrusions which are configured to be fitted into concave portions of intervertebral joints, a center hole into which the center rod is slidably inserted being formed in side surfaces of each of the connection plates so that the center of the center hole is on the back side of an imaginary line which connects middle points of arc-shaped contour lines of the concave portions of the neighboring intervertebral joints when viewed from the head side of a human body, and the connection plates being rotatable about the center rod. screws configured to be connected to vertebral bodies; at least two connection plates in each of which guide holes into which the screws are inserted from a back side surface toward a belly side surface are formed at both end portions; and a center rod which connects neighboring ones of the connection plates which are configured to be fixed to the vertebral bodies by the screws, each of the connection plates having, on the belly side surface, protrusions which are configured to be fitted into concave portions of intervertebral joints, a center hole into which the center rod is slidably inserted being formed in side surfaces of each of the connection plates so that the center of the center hole is on the back side of an imaginary line which connects middle points of arc-shaped contour lines of the concave portions of the neighboring intervertebral joints when viewed from the head side of a human body, and the connection plates being rotatable about the center rod.
A focal point adjusting apparatus comprising: a photoelectric converting unit that photoelectrically converts at least a pair of optical images and outputs at least a pair of image signals; a phase difference detecting unit that detects the phase difference between the pair of image signals that is output by the photoelectric conversion unit; a conversion unit that carries out the conversion of a phase difference that is detected by the phase difference detecting unit into a detected defocus amount by using a conversion coefficient; a focal point moving unit that moves the focal point position based on the detected defocus amount resulting of the conversion by the conversion unit; and a calibrating unit that calibrates the conversion coefficient depending on a result of comparing a detected defocus amount resulting from the conversion by the conversion unit before the focal point moving unit moving the focal point position and a detected_defocus amount resulting from the conversion by the conversion unit after the focal point moving unit moving the focal point position. a photoelectric converting unit that photoelectrically converts at least a pair of optical images and outputs at least a pair of image signals; a phase difference detecting unit that detects the phase difference between the pair of image signals that is output by the photoelectric conversion unit; a conversion unit that carries out the conversion of a phase difference that is detected by the phase difference detecting unit into a detected defocus amount by using a conversion coefficient; a focal point moving unit that moves the focal point position based on the detected defocus amount resulting of the conversion by the conversion unit; and a calibrating unit that calibrates the conversion coefficient depending on a result of comparing a detected defocus amount resulting from the conversion by the conversion unit before the focal point moving unit moving the focal point position and a detected_defocus amount resulting from the conversion by the conversion unit after the focal point moving unit moving the focal point position.
A closure for a flexible container, comprising a valve (7, 8) which is switchable between a closed position and an open position, and a tube structure arranged to be immersed in a liquid in the container, wherein the valve comprises a first part arranged to be inserted in an opening of the container and a second part arranged within the first part, said first and second parts (7, 8) being rotatable in relation to each other for switching between the closed position and the open position of the valve, wherein in the open position of the valve (7, 8) the tube structure communicates with a delivery line for delivery of the liquid and wherein a gas port in the closure communicates with a gas source for supply of propellant gas into the container; characterised in that the closure is made essentially of plastic material, and further characterised in that in the closed position of the valve (7, 8) the tube structure communicates with a headspace in the container via an evacuation port in the valve.
A method of preparing a compound of Formula or a pharmaceutically acceptable salt thereof: comprising the step of reacting a compound of Formula with a compound of formula in a Suzuki coupling reaction to form a compound of Formula: wherein, PG is a protecting group R1 is hydrogen, C 1 -C 6 alkyl optionally substituted by hydroxy; R2 is hydrogen or halogen; R3 is hydrogen or halogen; R4 is hydrogen; R5 is hydrogen or halogen; or R4 and R5 are attached to each other and stand for a bond, -CH 2 -, -CH 2 -CH 2 -, - CH=CH-, -CH=CH-CH 2 -; -CH 2 -CH=CH-; or -CH 2 -CH 2 -CH 2 -; R6 and R7 stand independently from each other for H, C 1 -C 6 alkyl optionally substituted by hydroxyl, C 3 -C 6 cycloalkyl optionally substituted by halogen or hydroxy, or halogen; R8, R9, R, R', R10 and R11 independently from each other stand for H, or C 1 -C 6 alkyl optionally substituted by C1-C6 alkoxy; or any two of R8, R9, R, R', R10 and R11 together with the carbon atom to which they are bound may form a 3 - 6 membered saturated carbocyclic ring; R12 is hydrogen or C 1 -C 6 alkyl optionally substituted by halogen or C 1 -C 6 alkoxy; or R12 and any one of R8, R9, R, R', R10 or R11 together with the atoms to which they are bound may form a 4, 5, 6 or 7 membered azacyclic ring, which ring may optionally be substituted by halogen, cyano, hydroxyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy; n is 0 or 1; and R13 is C 2 -C 6 alkenyl optionally substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy or N,N-di-C 1 -C 6 alkyl amino; C 2 -C 6 alkynyl optionally substituted by C 1 -C 6 alkyl or C 1 -C 6 alkoxy; or C 2 -C 6 alkylenyl oxide optionally substituted by C 1 -C 6 alkyl. PG is a protecting group R1 is hydrogen, C 1 -C 6 alkyl optionally substituted by hydroxy; R2 is hydrogen or halogen; R3 is hydrogen or halogen; R4 is hydrogen; R5 is hydrogen or halogen; or R4 and R5 are attached to each other and stand for a bond, -CH 2 -, -CH 2 -CH 2 -, - CH=CH-, -CH=CH-CH 2 -; -CH 2 -CH=CH-; or -CH 2 -CH 2 -CH 2 -; R6 and R7 stand independently from each other for H, C 1 -C 6 alkyl optionally substituted by hydroxyl, C 3 -C 6 cycloalkyl optionally substituted by halogen or hydroxy, or halogen; R8, R9, R, R', R10 and R11 independently from each other stand for H, or C 1 -C 6 alkyl optionally substituted by C1-C6 alkoxy; or any two of R8, R9, R, R', R10 and R11 together with the carbon atom to which they are bound may form a 3 - 6 membered saturated carbocyclic ring; R12 is hydrogen or C 1 -C 6 alkyl optionally substituted by halogen or C 1 -C 6 alkoxy; or R12 and any one of R8, R9, R, R', R10 or R11 together with the atoms to which they are bound may form a 4, 5, 6 or 7 membered azacyclic ring, which ring may optionally be substituted by halogen, cyano, hydroxyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy; n is 0 or 1; and R13 is C 2 -C 6 alkenyl optionally substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy or N,N-di-C 1 -C 6 alkyl amino; C 2 -C 6 alkynyl optionally substituted by C 1 -C 6 alkyl or C 1 -C 6 alkoxy; or C 2 -C 6 alkylenyl oxide optionally substituted by C 1 -C 6 alkyl.
A coated substrate comprising: a corrosion inhibition coating material; a substrate including at least one of a metal and a metal alloy, wherein the corrosion inhibition coating material is adhered to the substrate; and a carrier adapted to coat a substrate; wherein the corrosion inhibition coating material comprises a corrosion inhibition compound that is a polymer comprising a backbone and at least two inhibitor groups, wherein the inhibitor groups are linked to the corrosion inhibition compound with a labile linkage, wherein the labile linkage includes one of a disulfide bond, and a metal-sulfide bond, and further wherein the labile linkage is selected to dissociate in response to a corrosion stimulus to produce a dissociated inhibitor group. a corrosion inhibition coating material; a substrate including at least one of a metal and a metal alloy, wherein the corrosion inhibition coating material is adhered to the substrate; and a carrier adapted to coat a substrate;
A reverse osmosis system comprising: - a membrane housing comprising a reverse osmosis membrane therein, said membrane housing comprising a feed fluid input, a brine outlet and a permeate outlet; - a charge pump; - a plurality of valves (620, 630, 632, 640); and - a tank having a first volume separated from a second volume by a movable partition; wherein said plurality of valves (620, 630, 632, 640) are configured, in a first mode, to selectively couple the charge pump to the first volume while the brine outlet and the feed fluid input are connected to the second volume, and in a second mode, to selectively couple the charge pump to the second volume while the brine outlet and the feed fluid input are connected to the first volume, and wherein the first mode and the second mode are configured for alternating operation. - a membrane housing comprising a reverse osmosis membrane therein, said membrane housing comprising a feed fluid input, a brine outlet and a permeate outlet; - a charge pump; - a plurality of valves (620, 630, 632, 640); and - a tank having a first volume separated from a second volume by a movable partition;
An implant system comprising at least one elongated elastomeric implant body sized and configured for implantation in, on, or near a tongue or an extrinsic muscle of the tongue, applying tension to the tongue or extrinsic muscle of the tongue affecting movement and/or shape of the tongue, wherein the implant has a first extended state and a second relaxed state, means for stabilizing the position of the implant body relative to the tongue or extrinsic muscle of the tongue to maintain the tongue in a given orientation, and means for maintaining the implant in the first extended state for implantation of the implant, wherein the elongated elastomeric implant body comprises a spring.
Bow saw frame, of the type comprising a bow integral with a rear handle; a front attaching system connected to the bow and designed for attaching in the distal end of a saw blade, with this front system being mounted at the front end of the frame; a rear attaching system connected to the handle and designed for attaching the proximal end of the saw blade, the rear system being mounted to the rear end of the frame; a mechanism for tensioning a saw blade when it is attached to the front and rear attaching devices, said mechanism comprising a rotary control device coupled with a screw-nut system (52, 68), characterized in that the tensioning mechanism includes a disengageable rotary device, placed between the control device and the screw-nut system (52, 68), said device limiting the torque transmitted by the control device to the screw-nut system (52, 68) and in that the torque limiting device works by uncoupling the control device from the screw-nut system (52, 68), itself being attached to the rear attaching system when the control device is actuated in the direction of rotation corresponding to the tensioning of blade and when a torque threshold value is reached.
Battery holder (2, 22) for a hearing device, with an outer component (4, 24) and an inner component (6, 26), wherein the inner component (6, 26) is made of a different and harder material than the outer component (4, 24), wherein the inner component (6, 26) is designed to ensure that a battery inserted therein is held by it with a force fit and/or form fit, characterized in that overhangs, arranged on the inner component, and cutouts, arranged on the outer component and corresponding to the overhangs, form a force-fit and form-fit connection, or in that a force-fit and form-fit connection of inner component and outer component comprises an outer projection, arranged on the outer component, and a corresponding inner projection, arranged on the inner component, and also an outer bearing element and an inner bearing element.
A gas turbine engine comprising: a fan mounted inside a nacelle in serial flow communication with a compressor, combustor, high pressure turbine powering said compressor, and a low pressure turbine powering said fan; said HP turbine including a row of turbine rotor blades mounted inside a surrounding turbine shroud, with a radial gap therebetween; a heat exchanger disposed in a fan bypass duct inside said nacelle in flow communication with said compressor for using fan air to cool pressurized discharge air from said compressor; a distribution network disposed in flow communication with said heat exchanger, and including a plurality of valves for selectively distributing said compressor air to said HP turbine both outside said shroud and inside said blades; an active clearance control mount supporting said shroud around said blades; said network having a first circuit joining said heat exchanger in flow communication to said mount to channel the cooled compressor discharge air to said mount, and a second circuit joining said mount in flow communication to said blades to subsequently channel the cooled compressor discharge air to said blades; and a controller operatively joined to said valves in said network for adjusting flow of said compressor air through said first and second circuits (60,62). a fan mounted inside a nacelle in serial flow communication with a compressor, combustor, high pressure turbine powering said compressor, and a low pressure turbine powering said fan; said HP turbine including a row of turbine rotor blades mounted inside a surrounding turbine shroud, with a radial gap therebetween; a heat exchanger disposed in a fan bypass duct inside said nacelle in flow communication with said compressor for using fan air to cool pressurized discharge air from said compressor; a distribution network disposed in flow communication with said heat exchanger, and including a plurality of valves for selectively distributing said compressor air to said HP turbine both outside said shroud and inside said blades; an active clearance control mount supporting said shroud around said blades; said network having a first circuit joining said heat exchanger in flow communication to said mount to channel the cooled compressor discharge air to said mount, and a second circuit joining said mount in flow communication to said blades to subsequently channel the cooled compressor discharge air to said blades; and a controller operatively joined to said valves in said network for adjusting flow of said compressor air through said first and second circuits (60,62).
A method of preparing Compound: the method comprising reacting Compound: with furan; wherein the reaction is carried out in the absence of a Lewis acid; wherein the reaction is carried out in the absence of a perchlorate; wherein the reaction is carried out at around atmospheric pressure; and wherein the reaction is carried out in a solvent and the solvent is not an ionic liquid. wherein the reaction is carried out in the absence of a Lewis acid; wherein the reaction is carried out in the absence of a perchlorate; wherein the reaction is carried out at around atmospheric pressure; and wherein the reaction is carried out in a solvent and the solvent is not an ionic liquid.
A method for determining whether a patient having a deficiency in activity of a protein will respond to treatment with a specific pharmacological chaperone for the protein, which method comprises: a. contacting cells from a patient with a pharmacological chaperone specific for the protein; and b. comparing protein activity in cells not contacted with the specific pharmacological chaperone with protein activity in cells contacted with the specific pharmacological chaperone; wherein an increase in protein activity in cells contacted with the specific pharmacological chaperone over activity in cells not contacted with the specific pharmacological chaperone indicates that the patient will respond to treatment with the specific pharmacological chaperone; wherein the protein is α-galactosidase A; wherein the patient has been diagnosed with a Fabry disease; wherein the specific pharmacological chaperone is 1-deoxygalactonojirimycin; and wherein the cells are white blood cells and wherein the white blood cells are T lymphocytes and the contact with the specific pharmacological chaperone occurs in vitro. a. contacting cells from a patient with a pharmacological chaperone specific for the protein; and b. comparing protein activity in cells not contacted with the specific pharmacological chaperone with protein activity in cells contacted with the specific pharmacological chaperone; wherein an increase in protein activity in cells contacted with the specific pharmacological chaperone over activity in cells not contacted with the specific pharmacological chaperone indicates that the patient will respond to treatment with the specific pharmacological chaperone; wherein the protein is α-galactosidase A; wherein the patient has been diagnosed with a Fabry disease; wherein the specific pharmacological chaperone is 1-deoxygalactonojirimycin; and wherein the cells are white blood cells and wherein the white blood cells are T lymphocytes and the contact with the specific pharmacological chaperone occurs in vitro.